Literature DB >> 2193017

Immune recovery after bone marrow transplantation.

L G Lum1.   

Abstract

The donor-derived immune system that forms after bone marrow transplantation (BMT) takes as long as 2 years to develop in healthy BMT recipients. Soon after BMT, GVHD and its treatment increase the susceptibility of the recipient to overwhelming infections, and they retard the development of the immune system. The new system develops from a primitive state characterized by cytotoxic and suppressive functions and progresses to a mature state characterized by the development of specialized lymphocyte functions such as lymphokine production, proliferation, and expression of growth factor receptors. These specialized functions develop in healthy long-term recipients, whereas the same functions may be absent or impaired in those who develop chronic GVHD.

Entities:  

Mesh:

Year:  1990        PMID: 2193017

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  7 in total

Review 1.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

2.  Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.

Authors:  J Mattsson; M Uzunel; M Remberger; L Tammik; B Omazic; V Levitsky; J Z Zou; P Hentschke; O Ringdén
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

3.  Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice.

Authors:  S Funakoshi; D D Taub; M R Anver; A Raziuddin; O Asai; V Reddy; H Rager; W C Fanslow; D L Longo; W J Murphy
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

4.  Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT).

Authors:  I N Björk; C Brissac; M Remberger; J Mattsson; S Klaesson; O Ringdén; J Stewart; I Lundkvist
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

5.  Differential recovery of polymorphonuclear neutrophils, B and T cell subpopulations in the thymus, bone marrow, spleen and blood of mice following split-dose polychemotherapy.

Authors:  J E Talmadge; J D Jackson; C D Borgeson; G A Perry
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

6.  T cell receptor repertoire of CD4+ and CD8+ T cell subsets in the allogeneic bone marrow transplant recipient.

Authors:  F S Smith; S D Rencher; H E Heslop; J L Hurwitz
Journal:  Cancer Immunol Immunother       Date:  1995-08       Impact factor: 6.968

Review 7.  Epidemiology of infections in cancer patients.

Authors:  Teresa R Zembower
Journal:  Cancer Treat Res       Date:  2014
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.